Current stage-Stage II Posts on Medivizor
Navigation Menu

Current stage-Stage II Posts on Medivizor

Searching for patients with locally advanced non-small cell lung cancer to test a chemoradiotherapy regimen

Posted by on May 28, 2019 in Lung cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of standard chemoradiation vs a PET base chemoradiation combination in patients with non-small cell lung carcinoma (NSCLC). The main outcomes to be measured will be side effects and survival without cancer growing or spreading. The details A treatment option for...

Read More

Looking for participants with stage 2 to 4 rectal cancer to try a new targeted therapy treatment

Posted by on May 24, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness and safety of durvalumab (Imfinzi) in the treatment of advanced rectal cancer that is not prone to genetic abnormalities. The main outcomes to be measured will be tumor response to the treatment and side effects. This trial is being conducted in the US. The details The standard treatment...

Read More

Chemotherapy before breast conserving surgery in breast cancer – is there an increased risk of complications?

Posted by on May 21, 2019 in Breast cancer | 0 comments

In a nutshell This study investigated the effect of neoadjuvant chemotherapy (NAC; chemotherapy before surgery) in patients undergoing oncoplastic breast-conserving surgery (OBCS).  They found that NAC did not affect the rate of complications in OBCS.  Some background Breast cancer (BC) can be treated using a number of strategies....

Read More

Long-short radiation therapy before surgery is associated with better outcomes in stage 2 and 3 rectal cancer

Posted by on Apr 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared the survival outcomes of patients with rectal cancer who underwent short- or long-course radiation therapy (RT). Researchers suggested that long-course RT was associated with greater tumor response and survival. Some background Colorectal cancer is the third most common cancer diagnosed in the United States. The...

Read More

Consolidation chemotherapy before surgery improves the outcomes in advanced rectal cancer.

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of consolidation chemotherapy after initial treatment in locally advanced rectal cancer. Researchers suggested that this treatment is safe and is associated with improved cancer outcomes.  Some background Colorectal cancer is the fifth most common cancer. From all the colorectal...

Read More

Looking for patients with early rectal cancer to test less invasive surgery with chemotherapy

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness of chemotherapy followed by a less invasive surgery for early rectal cancer. The main outcome will be the number of patients keeping their rectum. This trial is being conducted in Canada and the United States. The details Rectal cancer is one of the most common cancers in the US. The standard...

Read More

Transanal endoscopic microsurgery after chemoradiotherapy improves rectal cancer outcomes

Posted by on Feb 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated long term rectal cancer outcomes in patients who received chemotherapy, radiation therapy, and transanal microsurgery. Researchers suggested that this treatment improves treatment outcomes and quality of life of patients. Some background The standard treatment for rectal cancer is surgery. However,...

Read More

Joint pain and falls among women with breast cancer on aromatase inhibitors.

Posted by on Jan 18, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if joint pain is associated with falling down in patients with breast cancer who were treated with aromatase inhibitors. The study found that the patients who reported having joint pain were more likely to have a fall than those who had no joint pain. Some background Aromatase inhibitors are medications...

Read More

Lymphocyte count reduction is associated with better rectal cancer outcomes

Posted by on Jan 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the relationship between lymphocyte (a type of white blood cells) counts and treatment outcomes for patients with rectal cancer. Researchers suggested that lymphocyte count reduction may be caused by rectal cancer treatment and is associated with better tumor response. Some background Colorectal cancer is the...

Read More

Length of treatment with trastuzumab in HER2+ early stage breast cancer

Posted by on Jan 2, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out what the best length of treatment with trastuzumab (Herceptin) is for HER2+ early stage breast cancer. The study found that at least one year of treatment had the best results in terms of how well it worked, and the cost-effectiveness. Some background HER-2 positive breast cancer is a type of cancer where...

Read More